MediWound Ltd. - Ordinary Shares (MDWD) earnings
MDWD earnings moved a median of -1.29% by the close. Quarterly and annual MDWD reports and results, each read against the price at its own news timestamp. Back to the MDWD overview →
19 measured MDWD earnings events.
Where these MDWD earnings landedvs 19 measured MDWD earnings reactions
| Middle 50% of MDWD earnings reactions | -2.45% to +0.62% |
|---|---|
| Median reaction (to close) | -1.29% |
| Measured reactions | 19 |
Point-in-time · zero look-ahead
Half of the 19 MDWD earnings events with a measured close landed between -2.45% and +0.62%; 32% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| MediWound Reports Second Quarter 2026 Financial Results and Provides Corporate Update | Press release | +1.83% | -3.77% | |
| MediWound to Report Second Quarter 2026 Financial Results | Press release | +0.96% | -1.71% | |
| MediWound Reports First Quarter 2026 Financial Results and Provides Corporate Update | Press release | -0.32% | -9.30% | |
| MediWound to Report First Quarter 2026 Financial Results | Press release | +0.00% | +0.17% | |
| MediWound Files Annual Report on Form 20-F | Press release | +0.23% | -0.87% | |
| MediWound Reports Third Quarter 2025 Financial Results and Provides Corporate Update | Press release | +0.63% | -3.66% | |
| MediWound to Report Third Quarter 2025 Financial Results | Press release | — | +1.06% | |
| MediWound Reports Second Quarter 2025 Financial Results and Provides Corporate Update | Press release | +1.29% | -0.16% | |
| MediWound to Report Second Quarter 2025 Financial Results | Press release | -0.43% | -2.08% | |
| MediWound Reports First Quarter 2025 Financial Results and Provides Corporate Update | Press release | +1.80% | -2.02% | |
| MediWound to Report First Quarter 2025 Financial Results | Press release | +0.29% | +3.08% | |
| MediWound Reports Third Quarter 2024 Financial Results and Provides Company Update | Press release | +2.70% | -0.94% | |
| MediWound to Report Third Quarter 2024 Financial Results | Press release | — | -2.48% | |
| MediWound Reports Second Quarter 2024 Financial Results and Provides Company Update | Press release | +7.50% | +2.70% | |
| MediWound to Report Second Quarter 2024 Financial Results | Press release | +2.48% | +3.07% | |
| MediWound Reports First Quarter 2024 Financial Results and Provides Company Update | Press release | +1.02% | -6.76% | |
| MediWound to Report First Quarter 2024 Financial Results | Press release | +0.00% | +3.59% | |
| MediWound Reports Third Quarter 2023 Financial Results and Provides Company Update | Press release | -0.12% | -1.29% | |
| MediWound to Report Third Quarter 2023 Financial Results | Press release | +0.00% | -2.42% |
Keep exploring
More MDWD: analyst actions → · SEC filings → · MDWD overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| CymaBay Therapeutics Inc. (CBAY) | 166 | +0.02% | 52% |
| Innoviva, Inc. (INVA) | 166 | +0.10% | 54% |
| XBiotech Inc. (XBIT) | 165 | 0.00% | 45% |
| Minerva Neurosciences, Inc (NERV) | 164 | 0.00% | 48% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.